Stay updated on Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a website version change rather than a modification to the study record content.
    Difference
    0.0%
    Check dated 2026-04-26T13:27:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T04:50:02.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was changed to Naples, Italy, 80131 in the location listings. The page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T07:50:45.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Related topics 'Prostate cancer' and 'MedlinePlus Genetics' have been removed from the page's related topics section, reducing quick-access navigation to those topics.
    Difference
    0.1%
    Check dated 2026-03-14T03:30:34.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Prostate cancer and MedlinePlus Genetics were added as related topics. The revision version was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T20:13:09.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:37:40.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.